One-Pot Green Synthesis and Biological Evaluation of Dimedone-Coupled 2,3-Dihydrofuran Derivatives to Divulge Their Inhibition Potential against Staphylococcal Thioredoxin Reductase Enzyme

被引:0
|
作者
Shukla, Manjari [1 ]
Mali, Ghanshyam [2 ]
Sharma, Supriya [2 ]
Maji, Sushobhan [1 ]
Yadav, Vinay Kumar [1 ]
Mishra, Amit [1 ]
Erande, Rohan D. [2 ]
Bhattacharyya, Sudipta [1 ]
机构
[1] Indian Inst Technol, Dept Biosci & Bioengn, Jodhpur 342037, Rajasthan, India
[2] Indian Inst Technol, Dept Chem, Jodhpur 342037, Rajasthan, India
来源
ACS OMEGA | 2024年 / 9卷 / 43期
关键词
4-COMPONENT SYNTHESIS;
D O I
10.1021/acsomega.4c04325
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
New therapeutic leads are in global demand against multiple drug-resistant Staphylococcus aureus, as presently there is no drug of choice left to treat this pathogen. In the present work, we have designed, synthesized, and in vitro validated dimedone-coupled 2,3-dihydrofuran (DDHF)-based inhibitor scaffolds against Staphylococcal thioredoxin reductase (SaTR), a pivotal drug target enzyme of Gram-positive pathogens. Accordingly, a green multicomponent method that is both efficient and one pot has been optimized to synthesize DDHF derivatives. The synthesized DDHF derivatives were found to inhibit a purified SaTR enzyme. The best inhibitor derivative, DDHF20, inhibits SaTR as a competitive inhibitor for the NADPH binding site at low micromolar concentrations. DDHF20-capped silver nanoparticles are synthesized and characterized, and their bactericidal property has been checked in vitro. Furthermore, detailed in silico-based structure-guided functional studies have been carried out to uncover the plausible mode of action of DDHF20 as a potential anti-Staphylococcal therapeutic lead.
引用
收藏
页码:43414 / 43425
页数:12
相关论文
共 4 条